[go: up one dir, main page]

BG28055A3 - Метод за получаване на фенилпиперазинови производни - Google Patents

Метод за получаване на фенилпиперазинови производни

Info

Publication number
BG28055A3
BG28055A3 BG037191A BG3719177A BG28055A3 BG 28055 A3 BG28055 A3 BG 28055A3 BG 037191 A BG037191 A BG 037191A BG 3719177 A BG3719177 A BG 3719177A BG 28055 A3 BG28055 A3 BG 28055A3
Authority
BG
Bulgaria
Prior art keywords
phenylperazine
derivatives
obtaining
proved
formulated
Prior art date
Application number
BG037191A
Other languages
English (en)
Inventor
John Verge
William Jamieson
Original Assignee
Lilly Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Limited filed Critical Lilly Industries Limited
Publication of BG28055A3 publication Critical patent/BG28055A3/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Метод за получаване на фенилпиперазинови про изводни, охарактеризирани и доказани в описанието с обща формула.... Патентните претенции са формулирани в 7 точки.
BG037191A 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни BG28055A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
BG28055A3 true BG28055A3 (bg) 1980-02-25

Family

ID=10078930

Family Applications (2)

Application Number Title Priority Date Filing Date
BG036062A BG27746A3 (bg) 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни
BG037191A BG28055A3 (bg) 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG036062A BG27746A3 (bg) 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни

Country Status (34)

Country Link
JP (1) JPS52151183A (bg)
AR (2) AR222003A1 (bg)
AT (1) AT355579B (bg)
AU (1) AU514822B2 (bg)
BE (1) BE853899A (bg)
BG (2) BG27746A3 (bg)
CA (1) CA1087617A (bg)
CH (2) CH633009A5 (bg)
CS (1) CS196360B2 (bg)
DD (1) DD129790A5 (bg)
DE (1) DE2717415A1 (bg)
DK (1) DK176177A (bg)
ES (2) ES457988A1 (bg)
FI (1) FI63937C (bg)
FR (1) FR2348925A1 (bg)
GB (1) GB1575904A (bg)
GR (1) GR64084B (bg)
HU (1) HU176820B (bg)
IE (1) IE44730B1 (bg)
IL (1) IL51787A (bg)
LU (1) LU77170A1 (bg)
MX (1) MX4596E (bg)
NL (1) NL7704456A (bg)
NO (1) NO146710C (bg)
NZ (1) NZ183715A (bg)
OA (1) OA05643A (bg)
PH (1) PH14124A (bg)
PL (1) PL117466B1 (bg)
PT (1) PT66452B (bg)
RO (1) RO72831A (bg)
SE (1) SE7704536L (bg)
SU (2) SU664564A3 (bg)
YU (1) YU104477A (bg)
ZA (1) ZA771849B (bg)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
AU686340B2 (en) * 1994-03-11 1998-02-05 Yamanouchi Pharmaceutical Co., Ltd. 5-HT3 receptor agonist, novel thiazole derivative, and intermediate therefor
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
BRPI0708337A2 (pt) * 2006-02-28 2011-05-24 Helicon Therapeutics Inc pipirazinas terapêutica como inibidores pde4

Also Published As

Publication number Publication date
FI63937C (fi) 1983-09-12
FR2348925B1 (bg) 1980-04-11
IL51787A0 (en) 1977-05-31
AU514822B2 (en) 1981-02-26
MX4596E (es) 1982-06-25
SU664564A3 (ru) 1979-05-25
AR222003A1 (es) 1981-04-15
CH625802A5 (en) 1981-10-15
RO72831A (ro) 1983-08-03
AU2438677A (en) 1978-10-26
HU176820B (en) 1981-05-28
FI771287A (bg) 1977-10-24
DD129790A5 (de) 1978-02-08
IE44730L (en) 1977-10-23
NO146710C (no) 1982-11-24
ATA285177A (de) 1979-08-15
JPS52151183A (en) 1977-12-15
DE2717415A1 (de) 1977-11-10
CS196360B2 (en) 1980-03-31
CA1087617A (en) 1980-10-14
SE7704536L (sv) 1977-10-24
GB1575904A (en) 1980-10-01
ZA771849B (en) 1978-11-29
ES457988A1 (es) 1978-07-16
PT66452A (en) 1977-05-01
AT355579B (de) 1980-03-10
BG27746A3 (bg) 1979-12-12
GR64084B (en) 1980-01-21
NL7704456A (nl) 1977-10-25
PL117466B1 (en) 1981-08-31
BE853899A (fr) 1977-10-24
NZ183715A (en) 1980-04-28
FR2348925A1 (fr) 1977-11-18
YU104477A (en) 1983-01-21
LU77170A1 (bg) 1979-01-18
NO146710B (no) 1982-08-16
SU727146A3 (ru) 1980-04-05
FI63937B (fi) 1983-05-31
IL51787A (en) 1980-02-29
PT66452B (en) 1979-03-09
ES467948A1 (es) 1978-11-01
PH14124A (en) 1981-02-26
AR222635A1 (es) 1981-06-15
PL197550A1 (pl) 1979-05-21
CH633009A5 (en) 1982-11-15
OA05643A (fr) 1981-04-30
IE44730B1 (en) 1982-03-10
DK176177A (da) 1977-10-24
RO72831B (ro) 1983-07-30
NO771398L (no) 1977-10-25

Similar Documents

Publication Publication Date Title
BG39467A3 (bg) Метод за получаване на карбоксиалкилни дипептиди
BG28052A4 (bg) Метод за получаване на аминоалкилхетероцикли
BG28061A3 (bg) Метод за получаване на хексахидродибензапираноли
BG33286A3 (bg) Метод за получаване на нови 4-хидрокси-2н-1,2 -бензотиазин-3-карбоксамид-1,1-двуориси,тяхната употреба и съдържащи тези съединения лекарствени средства
BG36044A3 (bg) Метод за получаване на пиперазинови производни
BG32850A3 (bg) Метод за получаване на 6а,10а-цис-хексахидро- -дибензопиранони
BG29722A3 (bg) Метод за получаване на 2,5-дисубституирани пиримидин-4-они
BG28699A3 (bg) Метод за получаване на алкилендиаминови производни
BG28068A3 (bg) Метод за получаване на -3- хлорцефалоспорини
BG28072A4 (bg) Метод за получаване на 1 n заместени канамицинови производни
BG28849A3 (bg) Метод за получаване на гамапирони
BG28573A3 (bg) Метод за получаване на аминоалкоксифенилови производни
BG30778A3 (bg) Метод за получаване на ебурнаменинови производни
BG34038A3 (bg) Метод за получаване на 7-заместени амино-ацетамидо оксадетиа-цефалоспорини
BG28987A4 (bg) Метод за получаване на n-(1,3,4-тиадиазол-2-ил)- бензамиди
BG31073A3 (bg) Метод за получаване на 1,5-заместени-2-пиролидони
BG28064A3 (bg) Метод за получаване на 26-метан-2н-1-бензоксозини
BG28055A3 (bg) Метод за получаване на фенилпиперазинови производни
BG30927A3 (bg) Метод за получаване на транс-4-алфа-фенил-октахидро-1н-2 пиридини
BG28054A3 (bg) Метод за получаване на 2-(4-ароил-пиперазин-1-ил)-4-амино-6,7- диметоксихиназолини
BG28845A3 (bg) Метод за получаване на n-алкилдифениламини
BG35032A3 (bg) Метод за получаване на 1, 1, 2- трифенилпропенови производни
BG28066A3 (bg) Метод за получаване на пиридобензодиазепинони
BG33436A3 (bg) Метод за получаване на 4-дезацетол-viw-3- спиро-5"-оксазилидин-2",4-дион
BG30926A3 (bg) Метод за получаване на n-(1-метил-2-пиролидинилметил-2,3-диметокси- 5-метилсулфамоилбензамид и негови производни